SCHEDULE: Puma Growth Holdings Acquires 5.07% Stake in Privia Health
Schedule 13D Filing
Puma Growth Holdings, LLC and its affiliates have disclosed beneficial ownership of 6,472,513 shares, representing 5.07% of Privia Health Group, Inc.'s common stock, acquired for investment purposes.
Summary
- Puma Growth Holdings, LLC, along with its affiliated entities Rubicon Founders OP GP, LP, Rubicon Founders OP GP 2 LLC, Rubicon Founders LLC, and Adam Boehler, have filed a Schedule 13D.
- These entities collectively beneficially own 6,472,513 shares of Privia Health Group, Inc. common stock.
- This ownership stake represents 5.07% of the total outstanding common stock as of July 31, 2026.
- The shares were acquired using working capital, with an aggregate of approximately $138,436,812 (excluding brokerage commissions) invested.
- The primary purpose of the acquisition was for investment, with the belief that the shares represented an attractive opportunity.
- The reporting persons intend to continuously review their investment and may communicate with the issuer's management, directors, or other stockholders.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily indicating a significant investment stake rather than an immediate strategic shift or performance update.
Positives
- Significant investment by Puma Growth Holdings and affiliates, indicating confidence in Privia Health's long-term prospects.
- Acquisition of a substantial 5.07% stake, demonstrating a notable commitment to the company.
- Investment made using existing working capital, suggesting no immediate need for external financing for this stake.
Negatives
- The filing does not provide specific details on the performance of Privia Health Group, Inc., focusing solely on the ownership stake.
- The stated intention to review investments and communicate with management could lead to future uncertainty or activism.
Risks
- Potential for future strategic actions or activism by Puma Growth Holdings and its affiliates, which could influence company strategy or governance.
- The reporting persons may engage in communications with various parties, potentially leading to market speculation or pressure on the issuer.
Future Outlook
The reporting persons intend to continuously review their investment in Privia Health Group, Inc. and may communicate with various parties, including management, directors, and other stockholders, regarding their investment.
Management Comments
- The principal business of each of the Reporting Persons is investment and/or investment management.
- The Reporting Persons originally acquired the Common Stock reported herein for investment purposes because they believed such shares represented an attractive investment opportunity.
- The Reporting Persons intend to review their investments in the Issuer on a continuing basis and in connection with such review communicate with officers and directors of the Issuer or other stockholders or third parties, such as industry analysts, existing or potential strategic partners, investment professionals and other investors.
Industry Context
StockSavvy.ai notes that significant stake acquisitions, as reported in this Schedule 13D, are common in the healthcare sector, often signaling a belief in the sector's growth potential or specific company strategies. This filing places Privia Health within a context where active investors may seek to influence or capitalize on market opportunities.
Stakeholder Impact
- Shareholders: May experience increased volatility or potential strategic shifts due to the significant stake held by Puma Growth Holdings and its stated intention to review and communicate.
- Management and Directors: May face engagement or pressure from Puma Growth Holdings regarding company strategy and operations.
- Other Investors: Will monitor the actions of Puma Growth Holdings and its affiliates, potentially influencing their own investment decisions.
Next Steps
- Continued review of investment in Privia Health Group, Inc. by Puma Growth Holdings and affiliates.
- Potential communication with Privia Health Group, Inc. management, directors, other stockholders, industry analysts, or potential strategic partners.
Key Dates
| Date | Description |
|---|---|
| 2026-07-07 | Sale of 100,000 shares at $27.21 per share. |
| 2026-07-13 | Sale of 97,557 shares at $27.65 per share. |
| 2026-08-06 | Purchase of 301,807 shares at $20.98 per share. |
| 2026-08-24 | Purchase of 51,521 shares at $21.00 per share. |
| 2026-08-25 | Purchase of 150,005 shares at $20.98 per share. |
| 2026-08-27 | Purchase of 100,000 shares at $20.90 per share. |
| 2026-09-01 | Purchase of 95,658 shares at $20.91 per share. |
| 2026-09-08 | Date of the Schedule 13D filing and Joint Filing Agreement. |
Recommendation
holdThe filing indicates a significant investment stake acquired for portfolio diversification and potential future engagement. While not a direct performance report, the acquisition of a 5.07% stake suggests a belief in the company's value. However, without further operational or financial updates from Privia Health, a 'hold' recommendation is prudent, pending clarity on Puma Growth Holdings' future intentions and any strategic discussions.
Keywords
Privia Health Group, Schedule 13D, Puma Growth Holdings, Rubicon Founders, Beneficial Ownership, Investment, Stock Acquisition, Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.